Similar articles for PMID: 30686754

Year	Number of Results
1977	1
1994	1
1997	1
2000	1
2001	1
2005	1
2009	2
2010	2
2011	2
2012	3
2013	4
2014	6
2015	12
2016	10
2017	12
2018	10
2019	8
2020	5
2021	3
2022	4
2024	0

1

Loss of SLC25A11 causes suppression of NSCLC and melanoma tumor formation.

Lee JS, Lee H, Lee S, Kang JH, Lee SH, Kim SG, Cho ES, Kim NH, Yook JI, Kim SY. Lee JS, et al. EBioMedicine. 2019 Feb;40:184-197. doi: 10.1016/j.ebiom.2019.01.036. Epub 2019 Jan 25. EBioMedicine. 2019. PMID: 30686754 Free PMC article.

2

Germline Mutations in the Mitochondrial 2-Oxoglutarate/Malate Carrier SLC25A11 Gene Confer a Predisposition to Metastatic Paragangliomas.

Buffet A, Morin A, Castro-Vega LJ, Habarou F, Lussey-Lepoutre C, Letouzé E, Lefebvre H, Guilhem I, Haissaguerre M, Raingeard I, Padilla-Girola M, Tran T, Tchara L, Bertherat J, Amar L, Ottolenghi C, Burnichon N, Gimenez-Roqueplo AP, Favier J. Buffet A, et al. Cancer Res. 2018 Apr 15;78(8):1914-1922. doi: 10.1158/0008-5472.CAN-17-2463. Epub 2018 Feb 5. Cancer Res. 2018. PMID: 29431636

3

SLC25A11 serves as a novel prognostic biomarker in liver cancer.

Pan G, Wang R, Jia S, Li Y, Jiao Y, Liu N. Pan G, et al. Sci Rep. 2020 Jun 18;10(1):9871. doi: 10.1038/s41598-020-66837-6. Sci Rep. 2020. PMID: 32555317 Free PMC article.

4

Oxoglutarate Carrier Inhibition Reduced Melanoma Growth and Invasion by Reducing ATP Production.

Lee JS, Choi J, Lee SH, Kang JH, Ha JS, Kim HY, Jang H, Yook JI, Kim SY. Lee JS, et al. Pharmaceutics. 2020 Nov 23;12(11):1128. doi: 10.3390/pharmaceutics12111128. Pharmaceutics. 2020. PMID: 33238375 Free PMC article.

5

Silencing of the mitochondrial NADH shuttle component aspartate-glutamate carrier AGC1/Aralar1 in INS-1E cells and rat islets.

Casimir M, Rubi B, Frigerio F, Chaffard G, Maechler P. Casimir M, et al. Biochem J. 2009 Dec 10;424(3):459-66. doi: 10.1042/BJ20090729. Biochem J. 2009. PMID: 19764902

6

MG53 suppresses tumor progression and stress granule formation by modulating G3BP2 activity in non-small cell lung cancer.

Li H, Lin PH, Gupta P, Li X, Zhao SL, Zhou X, Li Z, Wei S, Xu L, Han R, Lu J, Tan T, Yang DH, Chen ZS, Pawlik TM, Merritt RE, Ma J. Li H, et al. Mol Cancer. 2021 Sep 14;20(1):118. doi: 10.1186/s12943-021-01418-3. Mol Cancer. 2021. PMID: 34521423 Free PMC article.

7

Aberrant expression of embryonic mesendoderm factor MESP1 promotes tumorigenesis.

Tandon N, Goller K, Wang F, Soibam B, Gagea M, Jain AK, Schwartz RJ, Liu Y. Tandon N, et al. EBioMedicine. 2019 Dec;50:55-66. doi: 10.1016/j.ebiom.2019.11.012. Epub 2019 Nov 21. EBioMedicine. 2019. PMID: 31761621 Free PMC article.

8

The p53 Target Gene SIVA Enables Non-Small Cell Lung Cancer Development.

Van Nostrand JL, Brisac A, Mello SS, Jacobs SB, Luong R, Attardi LD. Van Nostrand JL, et al. Cancer Discov. 2015 Jun;5(6):622-35. doi: 10.1158/2159-8290.CD-14-0921. Epub 2015 Mar 26. Cancer Discov. 2015. PMID: 25813352 Free PMC article.

9

B-Myb Mediates Proliferation and Migration of Non-Small-Cell Lung Cancer via Suppressing IGFBP3.

Fan X, Wang Y, Jiang T, Cai W, Jin Y, Niu Y, Zhu H, Bu Y. Fan X, et al. Int J Mol Sci. 2018 May 16;19(5):1479. doi: 10.3390/ijms19051479. Int J Mol Sci. 2018. PMID: 29772705 Free PMC article.

10

Aldehyde dehydrogenase inhibition combined with phenformin treatment reversed NSCLC through ATP depletion.

Kang JH, Lee SH, Lee JS, Nam B, Seong TW, Son J, Jang H, Hong KM, Lee C, Kim SY. Kang JH, et al. Oncotarget. 2016 Aug 2;7(31):49397-49410. doi: 10.18632/oncotarget.10354. Oncotarget. 2016. PMID: 27384481 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

83 results

Results by year